Online Pharmacies Predicted to Thrive by 2003.
Published:
28 May 1999 y., Friday
The online consumer healthcare market will be worth $1.7 billion by 2003, according to a report by Jupiter Communications. Jupiter estimates that combined, the online and offline consumer healthcare market will generate 205.2 billion by 2003, with the online market accounting for less than one percent of the total. Online pharmacies will be the primary driving force of healthcare ecommerce in the short term, according to Jupiter. Further, the competition that the online sector is already providing is expected to bring off-line pharmacies online rapidly, in order to protect their market. Jupiter identified four core market segments. These are prescription harmaceuticals, over-the-counter drugs, nutraceuticals such as vitamin supplements, and personal care products. The study estimates that online prescription drug market will be worth $966 million by 2003, or .6 percent of the total market. The over-the-counter sector is predicted to generate $314 million dollars, with an annual compound growth rate of almost 216 percent. The sale of over-the-counter drugs is expected to outpace that of prescription drugs because the lack of legal and medical restrictions on their sale. Nonetheless, the enormity of the prescription drugs market means that even the small segment that the online market can corner will generate substantial revenue. The nutraceutical market is expected to be worth $434 million by 2003, up from a mere $1 million in 1998. The online personal care products market is expected to generate $706 million by 2003, up from $8 million in 1998. The compound annual growth rate is estimated at 145 percent.
Šaltinis:
Nua Surveys
Copying, publishing, announcing any information from the News.lt portal without written permission of News.lt editorial office is prohibited.
The most popular articles
The only physician in her village of Tsoniarisi, Mzevinar Bolkvadze sees patients all day in a newly built and equipped ambulatory.
more »
As of 7 September 2009, 48 of the 53 Member States in the WHO European Region had reported over 49 000 laboratory-confirmed cases of pandemic (H1N1) 2009 virus infection.
more »
China's food and drug administration say clinical trials of a vaccine against the H1N1 flu strain have been successful.
more »
As of 31 August 2009, 48 of the 53 Member States in the WHO European Region had reported laboratory-confirmed cases of pandemic (H1N1) 2009 virus infection.
more »
The European Union Health Security Committee and the Early Warning and Response authorities adopted a policy statement proposed by the European Commission which outlines a shared European approach towards identifying target and priority groups for A H1N1 vaccination.
more »
As of 20 August 2009, 47 of the 53 Member States in the WHO European Region had reported over 42 000 laboratory-confirmed cases of pandemic (H1N1) 2009 virus infection.
more »
About 1000 participants, mostly from North America, debated solutions to the obesity epidemic in the United States (US) at the Weight of the Nation conference, organized in Washington, USA, by the US Centers for Disease Control.
more »
The European Union Health Security Committee and the Early Warning and Response authorities (HSC/EWRS) unanimously adopted for the first time two policy statements proposed by the European Commission on public health measures for pandemic influenza A (H1N1) 2009.
more »
As of 10 August 2009, 46 of the 53 countries in the WHO European Region had reported over 33 000 laboratory-confirmed cases of pandemic (H1N1) 2009 virus infection, including 55 fatalities in 7 countries.
more »
The U.S. company Moog Medical Devices which acquired the company the Lithuanian Viltechmeda at the beginning of the year 2009, intends to invest EUR 2M in Lithuania in the nearest future, to establish a modern services centre.
more »